Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Using index level provides a macro view of market direction, helping you balance stock-specific decisions with overall sentiment.
27,685 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Wells Fargo trades near $79 as investors priced in about 16% upside over the next year, driven by regulatory relief, ...
Ford tumbled 7% intraday and Tesla slid 4% in a sentiment-driven retreat. Analysts say the fade stems from profit-tak...
Investors weigh whether SanDisk can sustain its rally as datacenter demand and hyperscaler contracts provide longer-t...
Adobe's AI push lifts revenue and unlocks upside for investors as shares hover near $253. This adobe price prediction...
SpaceX is set to debut on the public market tomorrow after planning a record-breaking raise, drawing unprecedented in...
Morningstar analysts warn SpaceX could be worth far less than its IPO price, focusing on profitability gaps and Starl...
An in-depth look at how much SCHD would be required to replace Social Security income, with current yields, market co...
Netflix faces a tough near-term trading backdrop after earnings, but a new price prediction points to 140% upside as ...
Three high-variance names—Moderna, Trade Desk, and MicroStrategy—reversed declines to rally in early March, signaling...
Travel finally bounced back, and hotel owners like Host Hotels faced a new set of challenges and opportunities. This ...
Looking to secure the best mortgage rate in 2026? This practical guide breaks down the steps that save you money: sha...